Green Swirl Background

Our Story

We are a bright, new beginning.

We are a company of scientists, a coalition of disruptors, making great advances and building a movement.

Cool couple holding hands on the beach

Our Founders’ Vision

Healthcare as you know it is about to see as much change in the next 10 years as there has been in the last 100 years, and those years were pretty remarkable. This extraordinary transformation will be available to everyone globally.

There are three pillars to this change. The first is we are entering a new moment in medical history where we are able to modify aging based on the work by brilliant scientists and their newfound insights into how cells age, the role of genes and proteins in human health and aging. For the first time in history, these same scientists have begun to understand how the body regenerates itself, allowing them to help stimulate your body to regenerate healthier tissues and even organs.

The second pillar is a complete change in how healthcare is being delivered from the hospitals, doctors, and the pharmaceutical industry through to the insurance companies or national healthcare. Today, all of these groups, their training, and business models are based on diagnosing a pathology or disease after you get sick and then create therapies to treat or potentially cure that disease. The new model that we are pursuing at Juvenescence is developing therapies that prevent these same pathologies and disease states, shifting away from the sick-treat paradigm for good.

The final pillar is unprecedented in biotech or pharmaceuticals. A company like Juvenescence will seek to democratize these health breakthroughs for everyone by harnessing clinically-validated but more economically available therapies, such as supplements, and leveraging social media to build awareness directly with the people who would most benefit from them.

We see the emergence of a new healthcare approach where science fiction becomes science. This new approach will empower people to make the appropriate lifestyle changes and take advantage of supplements and Rx therapies that will allow them to live longer and healthier. We are building Juvenescence to be an innovative biotech longevity company focused on all three of these pillars that will lead to one of the most exciting, disruptive, and sustainable health companies for decades to come.

Dr. Gregory Bailey, MD, Chief Executive Officer and co-founder of Juvenescence

Our Mission

Inspire and equip the world to reimagine a lifetime.

At Juvenescence, we’re on a mission to transform what aging means to the world. Science around aging is accelerating at an extraordinary pace, so we’ve set out to further that science and disrupt the thinking and behavior around aging. That’s why we built a coalition of the best scientists, physicians, and investors to create cutting-edge therapies and products that will empower people to chart their own path forward. So we're not just reimagining what it means to get older — we’re committed to helping you reimagine your lifetime.

Fun Surfing
Our Approach

We are organized with our partners into four divisions that drive scientific innovation.

Our Team

The Juvenescence team combines highly experienced scientists, drug developers, entrepreneurs and investors.

Working in the Lab Pink
Our Collaborators

We’re proud to work in tandem with research institutions across the globe.

In the News

Juvenescence

Forbes: ‘Extraordinary breakthroughs in Anti-Aging Research ‘Will Happen Faster Than People Think’

Scientific breakthroughs in anti-aging research have been occurring at an exponential pace, as highlighted in Forbes featuring Juvenescence CEO, Dr. Greg Bailey, MD.

August 25, 2019

Read More
Juvenescence

Allure: ‘Our Average Life Expectancy Could Increase to 115 Years Very Soon’

Dr. Greg Bailey, CEO of Juvenescence shares his insights on the future of aging with Allure. He discusses increasing lifespan in humans, a burst of investment in the longevity space and Juvenescence’s plans to bring that future to life.

August 17, 2020

Read More
Relation Therapeutics

Longevity Technology: 'Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19'

Relation Therapeutics and Mila, the Montreal-based AI research institute are collaborating on a new project targeting the development of COVID-19 therapeutics funded by the Bill & Melinda Gates Foundation.

September 1, 2020

Read More

Contact Us

We are here to help answer any questions you might have.